Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC)

NCT06350838 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-muscular Invasive Bladder Cancer

Interventions

DRUG: BCG for Therapeutic Use

Sponsor

Chengdu CoenBiotech Co., Ltd

Collaborators

[object Object]